MERCK KGAA
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1668-01-01
- Employees
- 62.9K
- Market Cap
- $84.2B
- Website
- http://www.merckgroup.com/de
To Assess the Prevalence of Spasticity and the Impact on the Quality of Life in Multiple Sclerosis Patients
Completed
- Conditions
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 150
- Registration Number
- NCT01080040
- Locations
- 🇦🇷
Fundación Rosarina de Neurorehabilitación, Rosario, Argentina
Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina
Completed
- Conditions
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 252
- Registration Number
- NCT01080014
- Locations
- 🇦🇷
Dr. Roberto Rosa, Buenos Aires, Argentina
Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)
Completed
- Conditions
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 306
- Registration Number
- NCT01080053
- Locations
- 🇦🇷
Dr. Norma Deri, Buenos Aires, Argentina
To Identify and Evaluate the Predictive Factors for Depression in Patients Diagnosed With Multiple Sclerosis
Completed
- Conditions
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2014-07-31
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 301
- Registration Number
- NCT01079975
- Locations
- 🇦🇷
Instituto de Investigacion Neurológica (Uruguay 840), Capital Federal, Buenos Aires, Argentina
An Active-controlled, Clinical Trial to Assess Central Hemodynamic Effects of Bisoprolol in Hypertensive Patients (Central Hemodynamic Assessment Measured in Patient With HypertensION [CHAMPION])
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2014-02-13
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 209
- Registration Number
- NCT01079962
- Locations
- 🇰🇷
Severance Hosptial, 250, Seongsanno, Seodaemungu, Seoul, Korea, Republic of
Safety, Tolerability and Adherence With Rebif® New Formulation in Real Life Settings (STAR)
Completed
- Conditions
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2014-07-31
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 254
- Registration Number
- NCT01080027
- Locations
- 🇬🇷
Neurology Clinic, General Hospital of Thessaloniki "G. Papanikolaou", Thessaloniki, Greece
A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 215
- Registration Number
- NCT01080066
- Locations
- 🇨🇳
Liouying Chi-Mei Hospital, Liouying, Tainan County, Taiwan
Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®
Completed
- Conditions
- First Posted Date
- 2010-02-25
- Last Posted Date
- 2013-09-06
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 300
- Registration Number
- NCT01075880
- Locations
- 🇨🇿
Neurologicka klinika FNBB, Brno, Czech Republic
🇨🇿Neurologicka klinika, Fakultní nemocnice U Sv. Anny, Brno, Czech Republic
🇨🇿Neurologicka klinika, Fakultní nemocnice, Olomouc, Czech Republic
A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease
- First Posted Date
- 2010-02-25
- Last Posted Date
- 2014-02-13
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 42
- Registration Number
- NCT01075763
- Locations
- 🇮🇹
U.VA. Neurologia - Azienda Ospedaliera Garibaldi Nesina, Catania, CT, Italy
A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-02-25
- Last Posted Date
- 2014-02-13
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 76
- Registration Number
- NCT01075815
- Locations
- 🇪🇸
FivMadrid, C/ Marqués de Urquijo, 26,, Madrid, Spain
© Copyright 2024. All Rights Reserved by MedPath